GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clal Biotechnology Industries Ltd (XTAE:CBI) » Definitions » Short-Term Debt

Clal Biotechnology Industries (XTAE:CBI) Short-Term Debt : ₪4.97 Mil (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Clal Biotechnology Industries Short-Term Debt?

Clal Biotechnology Industries's Short-Term Debt for the quarter that ended in Dec. 2023 was ₪4.97 Mil.

Clal Biotechnology Industries's quarterly Short-Term Debt stayed the same from Dec. 2022 (₪0.00 Mil) to Jun. 2023 (₪0.00 Mil) but then increased from Jun. 2023 (₪0.00 Mil) to Dec. 2023 (₪4.97 Mil).

Clal Biotechnology Industries's annual Short-Term Debt stayed the same from Dec. 2021 (₪0.00 Mil) to Dec. 2022 (₪0.00 Mil) but then increased from Dec. 2022 (₪0.00 Mil) to Dec. 2023 (₪4.97 Mil).


Clal Biotechnology Industries Short-Term Debt Historical Data

The historical data trend for Clal Biotechnology Industries's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clal Biotechnology Industries Short-Term Debt Chart

Clal Biotechnology Industries Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 4.97

Clal Biotechnology Industries Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Dec23
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 4.97

Clal Biotechnology Industries Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Clal Biotechnology Industries Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Clal Biotechnology Industries's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Clal Biotechnology Industries (XTAE:CBI) Business Description

Traded in Other Exchanges
N/A
Address
Azrieli Center, Triangle Building, 45th Floor, Tel Aviv, ISR, 67023
Clal Biotechnology Industries Ltd is a life sciences investment company. The company invests in companies ranging from seed to maturity, both public and private. Its portfolio of investments includes from heavy industry to biotechnology, hi-tech and energy companies.

Clal Biotechnology Industries (XTAE:CBI) Headlines

From GuruFocus

Van Den Berg Almost Sells Out 4 Stakes in 1st Quarter

By David Goodloe David Goodloe 04-20-2016

Does the Increase in Volatility Signal a Dangerous Market Environment?

By Chuck Carnevale Chuck Carnevale 11-11-2016

Chairman, CEO, CFO Purchase Shares in McDermott

By PRNewswire PRNewswire 11-07-2018

CB&I Announces Storage Award for Export Facility in Canada

By PRNewswire PRNewswire 04-26-2018

CB&I Announces DPC Technology Award in China

By PRNewswire PRNewswire 04-03-2018

Should We Devote Attention to Market Factors?

By Grahamites Grahamites 08-25-2015

CBI: Former Buffett Stock Worth Buying Now

By Jonathan Poland Jonathan Poland 06-29-2017